Download Files:
Products Details
Product Description
– Piribedil hydrochloride is a potent and orally active dopamine D2 and dopamine D3 agonist. Piribedil hydrochloride is also a α2-adrenoceptors antagonist. Piribedil hydrochloride can inhibit MLL1 methyltransferase activity (EC50: 0.18 μM). Piribedil hydrochloride has the potential for the research of parkinson’s disease, circulatory disorders, cancers[1][2][3][4].
Web ID
– HY-12707C
Shipping
– Room temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C16H19ClN4O2
References
– [1]Sweet RD, et al. Piribedil, a dopamine agonist, in Parkinson’s disease. Clin Pharmacol Ther. 1974 Dec;16(6):1077-82. |[2]Gerlach M, et al. The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson’s disease: differential role of α(2) adrenergic mechanisms. J Neural Transm (Vienna). 2013 Jan;120(1):31-6. |[3]Smith LA, Tet al. Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation. Mov Disord. 2002 Sep;17(5):887-901. |[4]Xiong Zhang, et al. Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis. Cancer Lett. 2018 Sep 1;431:150-160.
CAS Number
– 78213-63-5
Molecular Weight
– 334.80
SMILES
– [H]Cl.C1(N2CCN(CC3=CC=C(OCO4)C4=C3)CC2)=NC=CC=N1
Clinical Information
– Launched
Research Area
– Cancer; Endocrinology; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Adrenergic Receptor;Dopamine Receptor;Histone Methyltransferase
Isoform
– D2 Receptor;D3 Receptor;α adrenergic receptor
Pathway
– Epigenetics;GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
